Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Strong Sell

Analyst Rating

Strong Sell

Upgrade To View Simple Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Exponential Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Relative Strength Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Standard Deviation Rating

Upgrade

Upgrade To Get Access

Upgrade To View Williams %R Rating

Upgrade

Upgrade To Get Access

Upgrade To View Average Directional Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Insider Trading Rating

Upgrade

Upgrade To Get Access

Wall Street Data Solutions Rating

Sell

C

Harrow, Inc. Common Stock (HROW)

Pharmaceutical Preparations

https://www.harrow.com

Harrow Inc is a leading eyecare pharmaceutical company engaged in the discovery, development, and commercialization of innovative ophthalmic pharmaceutical products for the U.S. market. Harrow helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans each year.

102 WOODMONT BLVD, SUITE 610
NASHVILLE, TN

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

04/30/2007

Market Cap

1,366,801,308

Shares Outstanding

35,120,000

Weighted SO

35,117,746

Total Employees

N/A

Upcoming Earnings

08/14/2024

Similar Tickers

APYX --.--%

ETON --.--%

SCPH --.--%

FENC --.--%

EVLO --.--%

Beta

0.7740

Last Div

0.0000

Range

7.6-39.55

Chg

-0.4000

Avg Vol

525593

Mkt Cap

1366801308

Exch

NASDAQ

Country

US

Phone

615 733 4730

DCF Diff

4.4484

DCF

10.2816

Div Yield

0.0000

P/S

8.8669

EV Multiple

1335.8764

P/FV

23.6241

Div Yield %

0.0000

P/E

-40.8626

PEG

-1.4463

Payout

0.0000

Current Ratio

2.5945

Quick Ratio

2.4185

Cash Ratio

1.3252

DSO

123.6415

DIO

77.3740

Op Cycle

201.0155

DPO

165.6419

CCC

35.3736

Gross Margin

0.7116

Op Margin

-0.0529

Pretax Margin

-0.2071

Net Margin

-0.2178

Eff Tax Rate

-0.1503

ROA

-0.1097

ROE

-0.5089

ROCE

-0.0323

NI/EBT

1.0520

EBT/EBIT

3.9168

EBIT/Rev

-0.0529

Debt Ratio

0.6068

D/E

3.1990

LT Debt/Cap

0.7611

Total Debt/Cap

0.7618

Int Coverage

-0.7534

CF/Debt

0.0006

Equity Multi

5.2718

Rec Turnover

2.9521

Pay Turnover

2.2035

Inv Turnover

4.7173

FA Turnover

12.8199

Asset Turnover

0.5035

OCF/Share

0.0032

FCF/Share

-0.5822

Cash/Share

1.9924

OCF/Sales

0.0007

FCF/OCF

-181.9035

CF Coverage

0.0006

ST Coverage

0.1486

CapEx Coverage

0.0055

Div&CapEx Cov

0.0055

P/BV

23.6241

P/B

23.6241

P/S

8.8669

P/E

-40.8626

P/FCF

-65.9112

P/OCF

12035.4649

P/CF

12035.4649

PEG

-1.4463

P/S

8.8669

EV Multiple

1335.8764

P/FV

23.6241

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Jul 19, 05:31 Nicox announces attendance at upcoming conferences - GlobeNewswire GlobeNewswire Inc. Jul 16, 05:31 Nicox appoints experienced biotech leader Damian Marron as Chair of the Board and Marc Le Bozec as Director - GlobeNewswire

Revenue Product Segmentation